Study Says Synbiotic Drug That Alters Gut Microbiome Relieves Multiple Symptoms

An experimental drug that alters the gut microbiome could help relieve multiple symptoms of long COVID, a randomized controlled trial has revealed.

Post-acute COVID-19 syndrome (PACS), or long COVID, is a multisystem disorder that affects over 65 million people worldwide. As of now, there is no recognized and effective treatment for the condition that impacts the quality of life of those affected.

Several studies have shown the potential of probiotics in recovery from acute viral infections. Researchers from the Chinese University of Hong Kong studied the therapeutic effects of gut…